Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (81-90 of 385) with videos related to

Pageof 39
Sort By:
IEEE/ACM Transactions on Computational Biology and Bioinformatics|May 5, 2020
Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's DiseasePascal Schlosser, Jochen Knaus, Maximilian Schmutz, et al.
Oncotarget|December 30, 2016
Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cellsArefeh Rouhi, Christina Miller, Sarah Grasedieck, et al.
Blood|July 30, 2005
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsKonstanze Döhner, Richard F Schlenk, Marianne Habdank, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
International Journal of Cancer|June 23, 2015
Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemiaDaniela Opel, Andrea Schnaiter, Dagmar Dodier, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2022
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphomaAlexej Ballhausen, Amin Ben Hamza, Carlotta Welters, et al.
Scientific Reports|October 26, 2022
Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular productsKaty Haussmann, Mathias Streitz, Anna Takvorian, et al.
Epigenetics|May 29, 2014
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genesYing Qu, Andreas Lennartsson, Verena I Gaidzik, et al.
Palliative Care and Social Practice|July 24, 2024
Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessmentAnne Dörr, Insa Vogel, Friedrich Wittenbecher, et al.
Leukemia Research|November 1, 2024
In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technologyJosefine Krüger, Igor Wolfgang Blau, Olga Blau, et al.
Pageof 39

Showing results (81-90 of 385) with videos related to

Sort By:
Pageof 39
IEEE/ACM Transactions on Computational Biology and Bioinformatics|May 5, 2020
Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's DiseasePascal Schlosser, Jochen Knaus, Maximilian Schmutz, et al.
Oncotarget|December 30, 2016
Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cellsArefeh Rouhi, Christina Miller, Sarah Grasedieck, et al.
Blood|July 30, 2005
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsKonstanze Döhner, Richard F Schlenk, Marianne Habdank, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
International Journal of Cancer|June 23, 2015
Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemiaDaniela Opel, Andrea Schnaiter, Dagmar Dodier, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2022
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphomaAlexej Ballhausen, Amin Ben Hamza, Carlotta Welters, et al.
Scientific Reports|October 26, 2022
Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular productsKaty Haussmann, Mathias Streitz, Anna Takvorian, et al.
Epigenetics|May 29, 2014
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genesYing Qu, Andreas Lennartsson, Verena I Gaidzik, et al.
Palliative Care and Social Practice|July 24, 2024
Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessmentAnne Dörr, Insa Vogel, Friedrich Wittenbecher, et al.
Leukemia Research|November 1, 2024
In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technologyJosefine Krüger, Igor Wolfgang Blau, Olga Blau, et al.
Pageof 39